People with lupus who have certain antibodies are more likely to experience blood clots, researchers find
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Yuri Serna
TILs Plus Pembro Show Efficacy in GI Cancers
Neoantigen-specific tumor-infiltrating lymphocytes (TILs) plus pembrolizumab demonstrate efficacy against treatment-refractory gastrointestinal (GI) cancers in early results from a phase 2...
